Cargando…
Dual PPRαϒ Agonists for the Management of Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Saroglitazar is a novel medication for dyslipidemia, but its specific effects remain unclear. Therefore, we performed a systematic review and meta-analysis to assess the efficacy and safety of saroglitazar for managing dyslipidemia. The PubMed, Scopus, and EMBASE databases were systematically search...
Autores principales: | Menezes Junior, Antonio da Silva, Oliveira, Vinícius Martins Rodrigues, Oliveira, Izadora Caiado, de Sousa, André Maroccolo, Santana, Ana Júlia Prego, Carvalho, Davi Peixoto Craveiro, Paro Piai, Ricardo Figueiredo, Matos, Fernando Henrique, de Paiva, Arthur Marot, Reis, Gabriel Baêta Branquinho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488550/ https://www.ncbi.nlm.nih.gov/pubmed/37685742 http://dx.doi.org/10.3390/jcm12175674 |
Ejemplares similares
-
J/ψ and ϒ production at the LHC with ATLAS
por: CATMORE, JAMES
Publicado: (2011) -
Measurement of ϒ production in pp collisions at [Formula: see text]
por: Aaij, R., et al.
Publicado: (2012) -
ϒ→μ+μ- in 7 TeV pp collisions in ATLAS
por: Korn, A
Publicado: (2011) -
Flor de antigua poesía japonesa. Kokinsyῡ (siglo X)
por: Castro, Carlo Antonio, et al.
Publicado: (2019) -
Measuring high-energy neutrinos with FASERυ in the LHC Run-3
por: Kose, Umut
Publicado: (2021)